SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Incyte (INCY)
INCY 102.05+0.3%Nov 21 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cytokine1 who wrote (715)8/22/1998 3:20:00 AM
From: Richard Huth  Read Replies (2) of 3202
 
When I turned short INCY was around $31, yesterday we have been under $21. At this level (loss of over 30 % within four days) a correction was overdue and together with some recommendation upgrades we saw an intraday reversal.

For a short to medium term investor, I would not recommend to buy INCY above $23. Thanks to the low level we saw on Friday and to the upgrades by analyst, the price may move upward for the next few days.

But I fear when the first covering and buying run is over the stock will start to tumble again caused by decreasing investors interest (reasons see my prior posting). So for the moment I tend to stay on the side line (uninvested and just watching), even if I am long for the long run (2-4 years).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext